Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

AXIN1 knockout does not alter AMPK/mTORC1 regulation and glucose metabolism in mouse skeletal muscle

Research output: Contribution to journalJournal articlepeer-review

DOI

  1. The Journal of Physiology and the odyssey of 'neural control of the circulation during exercise'

    Research output: Contribution to journalEditorialpeer-review

  2. Resting in bed - how quickly does the muscle lose its nerve?

    Research output: Contribution to journalJournal articlepeer-review

  1. The regional turnover of cartilage collagen matrix in late-stage human knee osteoarthritis

    Research output: Contribution to journalJournal articlepeer-review

  2. Collagen Growth Pattern in Human Articular Cartilage of the Knee

    Research output: Contribution to journalJournal articlepeer-review

  3. Mutual stimulatory signaling between human myogenic cells and rat cerebellar neurons

    Research output: Contribution to journalJournal articlepeer-review

  4. Mutual stimulatory signalling between human myogenic cells and rat cerebellar neurons

    Research output: Contribution to journalJournal articlepeer-review

  • Jingwen Liu
  • Jonas Roland Knudsen
  • Carlos Henriquez-Olguin
  • Zhencheng Li
  • Jesper Bratz Birk
  • Kaspar W Persson
  • Ylva Hellsten
  • Anika Offergeld
  • William Jarassier
  • Fabien Le Grand
  • Peter Schjerling
  • Jørgen F P Wojtaszewski
  • Thomas E Jensen
View graph of relations
Key points: Tamoxifen-inducible skeletal muscle-specific AXIN1 knockout (AXIN1 imKO) in mouse does not affect whole-body energy substrate metabolism. AXIN1 imKO does not affect AICAR or insulin-stimulated glucose uptake in adult skeletal muscle. AXIN1 imKO does not affect adult skeletal muscle AMPK or mTORC1 signalling during AICAR/insulin/amino acid incubation, contraction and exercise. During exercise, α2/β2/γ3AMPK and AMP/ATP ratio show greater increases in AXIN1 imKO than wild-type in gastrocnemius muscle.

Abstract: AXIN1 is a scaffold protein known to interact with >20 proteins in signal transduction pathways regulating cellular development and function. Recently, AXIN1 was proposed to assemble a protein complex essential to catabolic-anabolic transition by coordinating AMPK activation and inactivation of mTORC1 and to regulate glucose uptake-stimulation by both AMPK and insulin. To investigate whether AXIN1 is permissive for adult skeletal muscle function, a phenotypic in vivo and ex vivo characterization of tamoxifen-inducible skeletal muscle-specific AXIN1 knockout (AXIN1 imKO) mice was conducted. AXIN1 imKO did not influence AMPK/mTORC1 signalling or glucose uptake stimulation at rest or in response to different exercise/contraction protocols, pharmacological AMPK activation, insulin or amino acids stimulation. The only genotypic difference observed was in exercising gastrocnemius muscle, where AXIN1 imKO displayed elevated α2/β2/γ3 AMPK activity and AMP/ATP ratio compared to wild-type mice. Our work shows that AXIN1 imKO generally does not affect skeletal muscle AMPK/mTORC1 signalling and glucose metabolism, probably due to functional redundancy of its homologue AXIN2.
Original languageEnglish
JournalThe Journal of physiology
Volume599
Issue number12
Pages (from-to)3081-3100
Number of pages20
ISSN0022-3751
DOIs
Publication statusPublished - 15 Jun 2021

    Research areas

  • AMPK, exercise, glucose metabolism, insulin, mTORC1

ID: 70589718